JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB90283

Native Human IgG1 protein

Be the first to review this product! Submit a review

|

(11 Publications)

Native Human IgG1 protein is a Human Full Length IgG1 protein with >95% purity and suitable for SDS-PAGE and ELISA. The predicted molecular weight of ab90283 native protein is 146 kDa.

- Save time and ensure accurate result-use our native IgG1 protein as an isotype control
- No cross-reaction from other immunoglobulin isotypes

View Alternative Names

Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1

1 Images
ELISA - Native Human IgG1 protein (AB90283)
  • ELISA

Lab

ELISA - Native Human IgG1 protein (AB90283)

The wells were coated with Anti-Human IgG antibody [IG266] (ab200699) at 5μg/ml at 50μl/well overnight at 4°C, followed by a 5% BSA blocking step for 2h RT. Human IgG1 (ab90283) was then added starting at 100 μg/ml and plasma/serum at 1 : 50 and gradually diluted 1 : 4, 50μl/well for 2h. ab201485 was then added at 1 : 10,000 dilution, 50μl/well for 2h. A HRP-streptavidin (ab7403) was used at 1 : 10,000 dilution for 1h.

Key facts

Purity

>95% SDS-PAGE

Expression system

Native

Tags

Tag free

Applications

ELISA, SDS-PAGE

applications

Biologically active

No

Accession

P01857

Animal free

No

Carrier free

No

Species

Human

Storage buffer

pH: 7.4 Preservative: 0.05% Sodium azide Constituents: 0.87% Sodium chloride, 0.3% Sodium phosphate monobasic, monohydrate

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

You may be interested in:

AB195215

Human IgG ELISA Kit

4

6 Reviews

View product

We recommend this product because it’s often used in the same experiment or related research.

We advise that you always check the datasheet to ensure it fits your experiments, or contact ourtechnical teamfor help.

Product details

The Native Human IgG1 protein ab90283 is prepared from plasma shown to be non reactive for HBsAg, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests.

Ensure the validity of your result using our native human IgG1 protein as an isotype control in SDS-PAGE. Analyze your IgG1 ELISA data using the ab90283 protein to generate and plot a standard curve.

Check out our protein gel staining guide for SDS-PAGE here

Check out our ELISA protocol for more information here.

Protein Determination: Extinction Coefficient (ε) 0.1% at 280 nm = 1.36

Sequence info

[{"sequence":"","proteinLength":"Full Length","predictedMolecularWeight":"146 kDa","actualMolecularWeight":null,"aminoAcidEnd":0,"aminoAcidStart":0,"nature":"Native","expressionSystem":null,"accessionNumber":"P01857","tags":[]}]

Properties and storage information

Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
False

Specifications

Form

Liquid

General info

Function

Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed : 20176268, PubMed : 22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed : 17576170, PubMed : 20176268). Mediates IgG effector functions on monocytes triggering ADCC of virus-infected cells.

Post-translational modifications

Glycosylation on Asn-180 is required for interaction with Fc receptors and ability to activate the complement pathway.. (Microbial infection) Deglycosylation on Asn-180 by S.pyogenes EndoS or Endos2 endoglucosidases prevents interaction between immunoglobulin-gamma (IgG) and Fc receptors, impairing ability to activate the complement pathway.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed : 20176268, PubMed : 22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed : 17576170, PubMed : 20176268). Mediates IgG effector functions on monocytes triggering ADCC of virus-infected cells.
See full target information IGHG1

Publications (11)

Recent publications for all applications. Explore the full list and refine your search

The Journal of biological chemistry 300:105623 PubMed38176650

2024

Molecular characterization of the interaction between human IgG and the M-related proteins from Streptococcus pyogenes.

Applications

Unspecified application

Species

Unspecified reactive species

Emma-Jayne Proctor,Hannah R Frost,Sandeep Satapathy,Gwenaëlle Botquin,Joanna Urbaniec,Jody Gorman,David M P De Oliveira,Jason McArthur,Mark R Davies,Anne Botteaux,Pierre Smeesters,Martina Sanderson-Smith

PLoS computational biology 19:e1011109 PubMed37934786

2023

Quantitative mechanistic model reveals key determinants of placental IgG transfer and informs prenatal immunization strategies.

Applications

Unspecified application

Species

Unspecified reactive species

Remziye E Wessel,Sepideh Dolatshahi

Scientific reports 13:13166 PubMed37574522

2023

Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination depends on prior infection history.

Applications

Unspecified application

Species

Unspecified reactive species

Petra Kiszel,Pál Sík,János Miklós,Erika Kajdácsi,György Sinkovits,László Cervenak,Zoltán Prohászka

Scientific reports 12:19759 PubMed36396679

2022

Evidence, detailed characterization and clinical context of complement activation in acute multisystem inflammatory syndrome in children.

Applications

Unspecified application

Species

Unspecified reactive species

György Sinkovits,János Schnur,Lisa Hurler,Petra Kiszel,Zita Z Prohászka,Pál Sík,Erika Kajdácsi,László Cervenak,Veronika Maráczi,Máté Dávid,Borbála Zsigmond,Éva Rimanóczy,Csaba Bereczki,Loek Willems,Erik J M Toonen,Zoltán Prohászka

Scientific reports 11:23491 PubMed34873223

2021

A 1-minute blood test detects decreased immune function and increased clinical risk in COVID-19 patients.

Applications

Unspecified application

Species

Unspecified reactive species

Chirajyoti Deb,Allan N Salinas,Tianyu Zheng,Aurea Middleton,Katelyn Kern,Daleen Penoyer,Rahul Borsadia,Charles Hunley,Bassam Abomoelak,Vijay Mehta,Laura Irastorza,Devendra I Mehta,Qun Huo

Biomedicines 9: PubMed34572313

2021

The FcγRIII Engagement Augments PMA-Stimulated Neutrophil Extracellular Traps (NETs) Formation by Granulocytes Partially via Cross-Talk between Syk-ERK-NF-κB and PKC-ROS Signaling Pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Cheng-Hsun Lu,Ko-Jen Li,Cheng-Han Wu,Chieh-Yu Shen,Yu-Min Kuo,Song-Chou Hsieh,Chia-Li Yu

Cell reports 30:905-913.e6 PubMed31968262

2020

Memory B Cell Activation, Broad Anti-influenza Antibodies, and Bystander Activation Revealed by Single-Cell Transcriptomics.

Applications

Unspecified application

Species

Unspecified reactive species

Felix Horns,Cornelia L Dekker,Stephen R Quake

Arteriosclerosis, thrombosis, and vascular biology 39:1884-1892 PubMed31315438

2019

Association Between ApoA-I (Apolipoprotein A-I) Immune Complexes and Adverse Cardiovascular Events-Brief Report.

Applications

Unspecified application

Species

Unspecified reactive species

David Henson,Ayman Samman Tahhan,David Nardo,Arshed Ali Quyyumi,Vincent J Venditto

Frontiers in immunology 9:1646 PubMed30061898

2018

Concentration and Subclass Distribution of Anti-ADAMTS13 IgG Autoantibodies in Different Stages of Acquired Idiopathic Thrombotic Thrombocytopenic Purpura.

Applications

Unspecified application

Species

Unspecified reactive species

György Sinkovits,Ágnes Szilágyi,Péter Farkas,Dóra Inotai,Anikó Szilvási,Attila Tordai,Katalin Rázsó,Marienn Réti,Zoltán Prohászka

Journal of immunological methods 455:41-54 PubMed29397157

2018

Development of quantitative suspension array assays for six immunoglobulin isotypes and subclasses to multiple Plasmodium falciparum antigens.

Applications

Unspecified application

Species

Unspecified reactive species

Marta Vidal,Ruth Aguilar,Joseph J Campo,Carlota Dobaño
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Associated Products

Select an associated product type
Alternative Product
Proteins & Peptides

AB184886

Native Human IgG1 protein

proteins-peptides

native-human-igg1-protein-ab184886

0

(0 reviews)

Alternative Product
Proteins & Peptides

AB155632

Recombinant human IgG1 protein (Active)

proteins-peptides

recombinant-human-igg1-protein-active-ab155632

0

(0 reviews)

Alternative Product
Proteins & Peptides

AB180055

Recombinant Mouse IgG1 protein

proteins-peptides

recombinant-mouse-igg1-protein-ab180055

0

(0 reviews)

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com